Isolated pulmonary valve replacement: Analysis of 27 years of experience

Shigehiko Tokunaga, Munetaka Masuda, Akira Shiose, Yukihiro Tomita, Shigeki Morita, Ryuji Tominaga

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The aim of this study was to investigate the longterm results of isolated pulmonary valve replacement using xenobioprostheses or mechanical valves. Twenty-four cases of isolated pulmonary valve replacement carried out at Kyushu University Hospital between 1977 and 2004 were reviewed. Those undergoing Rastelli's operation were excluded from this study. Bioprostheses were used in 18 patients and mechanical valves in 6. There were no operative deaths. Two patients with mechanical valves needed repeat pulmonary valve replacement due to thrombosed valves. The patients with bioprostheses had no need of repeat replacement postoperatively. The cardiothoracic ratio significantly improved from 60.3% preoperatively to 55.4% postoperatively (P < 0.05), and the New York Heart Association (NYHA) class significantly improved from 2.0 preoperatively to 1.1 postoperatively (P < 0.05). The actuarial survival rate at 15 years was 92.3%. The valve-related event-free ratio at 15 years was 85.7% in the bioprosthesis group and 66.7% in the mechanical valve group, with no significant difference. Isolated pulmonary valve replacement with bioprostheses or mechanical valves can be safely done and showed satisfactory long-term results. The mechanical valve group demonstrated a high ratio of thrombosed valves. A bioprosthesis is recommended for pulmonary valve replacement if a homograft is not available.

Original languageEnglish
Pages (from-to)130-133
Number of pages4
JournalJournal of Artificial Organs
Volume11
Issue number3
DOIs
Publication statusPublished - Sep 1 2008

Fingerprint

Bioprosthesis
Pulmonary Valve
Allografts
Thrombosis
Survival Rate

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering
  • Cardiology and Cardiovascular Medicine

Cite this

Isolated pulmonary valve replacement : Analysis of 27 years of experience. / Tokunaga, Shigehiko; Masuda, Munetaka; Shiose, Akira; Tomita, Yukihiro; Morita, Shigeki; Tominaga, Ryuji.

In: Journal of Artificial Organs, Vol. 11, No. 3, 01.09.2008, p. 130-133.

Research output: Contribution to journalArticle

Tokunaga, Shigehiko ; Masuda, Munetaka ; Shiose, Akira ; Tomita, Yukihiro ; Morita, Shigeki ; Tominaga, Ryuji. / Isolated pulmonary valve replacement : Analysis of 27 years of experience. In: Journal of Artificial Organs. 2008 ; Vol. 11, No. 3. pp. 130-133.
@article{7fb02d93e640442bbd2e3890dd852bc2,
title = "Isolated pulmonary valve replacement: Analysis of 27 years of experience",
abstract = "The aim of this study was to investigate the longterm results of isolated pulmonary valve replacement using xenobioprostheses or mechanical valves. Twenty-four cases of isolated pulmonary valve replacement carried out at Kyushu University Hospital between 1977 and 2004 were reviewed. Those undergoing Rastelli's operation were excluded from this study. Bioprostheses were used in 18 patients and mechanical valves in 6. There were no operative deaths. Two patients with mechanical valves needed repeat pulmonary valve replacement due to thrombosed valves. The patients with bioprostheses had no need of repeat replacement postoperatively. The cardiothoracic ratio significantly improved from 60.3{\%} preoperatively to 55.4{\%} postoperatively (P < 0.05), and the New York Heart Association (NYHA) class significantly improved from 2.0 preoperatively to 1.1 postoperatively (P < 0.05). The actuarial survival rate at 15 years was 92.3{\%}. The valve-related event-free ratio at 15 years was 85.7{\%} in the bioprosthesis group and 66.7{\%} in the mechanical valve group, with no significant difference. Isolated pulmonary valve replacement with bioprostheses or mechanical valves can be safely done and showed satisfactory long-term results. The mechanical valve group demonstrated a high ratio of thrombosed valves. A bioprosthesis is recommended for pulmonary valve replacement if a homograft is not available.",
author = "Shigehiko Tokunaga and Munetaka Masuda and Akira Shiose and Yukihiro Tomita and Shigeki Morita and Ryuji Tominaga",
year = "2008",
month = "9",
day = "1",
doi = "10.1007/s10047-008-0413-8",
language = "English",
volume = "11",
pages = "130--133",
journal = "Journal of Artificial Organs",
issn = "1434-7229",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Isolated pulmonary valve replacement

T2 - Analysis of 27 years of experience

AU - Tokunaga, Shigehiko

AU - Masuda, Munetaka

AU - Shiose, Akira

AU - Tomita, Yukihiro

AU - Morita, Shigeki

AU - Tominaga, Ryuji

PY - 2008/9/1

Y1 - 2008/9/1

N2 - The aim of this study was to investigate the longterm results of isolated pulmonary valve replacement using xenobioprostheses or mechanical valves. Twenty-four cases of isolated pulmonary valve replacement carried out at Kyushu University Hospital between 1977 and 2004 were reviewed. Those undergoing Rastelli's operation were excluded from this study. Bioprostheses were used in 18 patients and mechanical valves in 6. There were no operative deaths. Two patients with mechanical valves needed repeat pulmonary valve replacement due to thrombosed valves. The patients with bioprostheses had no need of repeat replacement postoperatively. The cardiothoracic ratio significantly improved from 60.3% preoperatively to 55.4% postoperatively (P < 0.05), and the New York Heart Association (NYHA) class significantly improved from 2.0 preoperatively to 1.1 postoperatively (P < 0.05). The actuarial survival rate at 15 years was 92.3%. The valve-related event-free ratio at 15 years was 85.7% in the bioprosthesis group and 66.7% in the mechanical valve group, with no significant difference. Isolated pulmonary valve replacement with bioprostheses or mechanical valves can be safely done and showed satisfactory long-term results. The mechanical valve group demonstrated a high ratio of thrombosed valves. A bioprosthesis is recommended for pulmonary valve replacement if a homograft is not available.

AB - The aim of this study was to investigate the longterm results of isolated pulmonary valve replacement using xenobioprostheses or mechanical valves. Twenty-four cases of isolated pulmonary valve replacement carried out at Kyushu University Hospital between 1977 and 2004 were reviewed. Those undergoing Rastelli's operation were excluded from this study. Bioprostheses were used in 18 patients and mechanical valves in 6. There were no operative deaths. Two patients with mechanical valves needed repeat pulmonary valve replacement due to thrombosed valves. The patients with bioprostheses had no need of repeat replacement postoperatively. The cardiothoracic ratio significantly improved from 60.3% preoperatively to 55.4% postoperatively (P < 0.05), and the New York Heart Association (NYHA) class significantly improved from 2.0 preoperatively to 1.1 postoperatively (P < 0.05). The actuarial survival rate at 15 years was 92.3%. The valve-related event-free ratio at 15 years was 85.7% in the bioprosthesis group and 66.7% in the mechanical valve group, with no significant difference. Isolated pulmonary valve replacement with bioprostheses or mechanical valves can be safely done and showed satisfactory long-term results. The mechanical valve group demonstrated a high ratio of thrombosed valves. A bioprosthesis is recommended for pulmonary valve replacement if a homograft is not available.

UR - http://www.scopus.com/inward/record.url?scp=53949112234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53949112234&partnerID=8YFLogxK

U2 - 10.1007/s10047-008-0413-8

DO - 10.1007/s10047-008-0413-8

M3 - Article

C2 - 18836873

AN - SCOPUS:53949112234

VL - 11

SP - 130

EP - 133

JO - Journal of Artificial Organs

JF - Journal of Artificial Organs

SN - 1434-7229

IS - 3

ER -